Exosomes from Hepatitis C Infected Patients Transmit HCV Infection and Contain Replication Competent Viral RNA in Complex with Ago2-miR122-HSP90

PLoS Pathogens

Volumn 10, Issue 10, 2014, Pages

  Bukong, Terence N ^a   Momen Heravi, Fatemeh ^a   Kodys, Karen ^a   Bala, Shashi ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; ARGONAUTE 2 PROTEIN; BAFILOMYCIN A1; CD81 ANTIGEN; HEAT SHOCK PROTEIN 90; LACTATE DEHYDROGENASE; LANSOPRAZOLE; MICRORNA 122; TELAPREVIR; VIRUS RNA; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; MICRORNA; MIRN122 MICRORNA, HUMAN; PROTEIN BINDING; VIRUS RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE TRANSMISSION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; GENE TRANSFER; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING; CELL CULTURE; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; LIVER CELL; METABOLISM; PHYSIOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

ARGONAUTE PROTEINS; CELLS, CULTURED; EXOSOMES; HEPACIVIRUS; HEPATOCYTES; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MICRORNAS; PROTEIN BINDING; RECEPTORS, VIRUS; RNA, VIRAL; VIRUS REPLICATION;

EID: 84908349078     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004424     Document Type: Article

References (65)

1. Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. The Lancet infectious diseases 5: 558–567.
2. Negro F, Alberti A, (2011) The global health burden of hepatitis C virus infection. Liver international : official journal of the International Association for the Study of the Liver 31 Suppl 2: 1–3.
3. Scheel TK, Rice CM, (2013) Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nature medicine 19: 837–849.
4. Rubin A, Aguilera V, Berenguer M, (2011) Liver transplantation and hepatitis C. Clinics and research in hepatology and gastroenterology 35: 805–812.
5. Forman LM, (2003) To transplant or not to transplant recurrent hepatitis C and liver failure. Clinics in liver disease 7: 615–629.
6. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 17–24.
7. Morin TJ, Broering TJ, Leav BA, Blair BM, Rowley KJ, et al. (2012) Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS pathogens 8: e1002895.
8. Gottwein JM, Bukh J, (2008) Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Advances in virus research 71: 51–133.
9. Zeisel MB, Fofana I, Fafi-Kremer S, Baumert TF, (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Journal of hepatology 54: 566–576.
10. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. The EMBO journal 21: 5017–5025.
11. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, et al. (1998) Binding of hepatitis C virus to CD81. Science 282: 938–941.
12. Meuleman P, Hesselgesser J, Paulson M, Vanwolleghem T, Desombere I, et al. (2008) Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48: 1761–1768.
13. Davis GL, (2006) Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12: 1317–1319.
14. Mancini N, Diotti RA, Perotti M, Sautto G, Clementi N, et al. (2009) Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes. PloS one 4: e8254.
15. Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, et al. (2006) Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12: 1381–1389.
16. Witteveldt J, Evans MJ, Bitzegeio J, Koutsoudakis G, Owsianka AM, et al. (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. The Journal of general virology 90: 48–58.
17. Lee Y, El Andaloussi S, Wood MJ, (2012) Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Human molecular genetics 21: R125–134.
18. Thery C, Zitvogel L, Amigorena S, (2002) Exosomes: composition, biogenesis and function. Nature reviews Immunology 2: 569–579.
19. Momen-Heravi F, Balaj L, Alian S, Tigges J, Toxavidis V, et al. (2012) Alternative methods for characterization of extracellular vesicles. Frontiers in physiology 3: 354.
20. Yang M, Chen J, Su F, Yu B, Su F, et al. (2011) Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Molecular cancer 10: 117.
21. Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, et al. (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. Journal of virology 76: 4008–4021.
22. Gastaminza P, Dryden KA, Boyd B, Wood MR, Law M, et al. (2010) Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. Journal of virology 84: 10999–11009.
23. Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, et al. (2004) Association of hepatitis C virus envelope proteins with exosomes. European journal of immunology 34: 2834–2842.
24. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, et al. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12: 558–570.
25. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature medicine 11: 791–796.
26. Wilson JA, Zhang C, Huys A, Richardson CD, (2011) Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. Journal of virology 85: 2342–2350.
27. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, et al. (2008) microRNA-122 stimulates translation of hepatitis C virus RNA. The EMBO journal 27: 3300–3310.
28. Jopling CL, Schutz S, Sarnow P, (2008) Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell host & microbe 4: 77–85.
29. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P, (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577–1581.
30. Jangra RK, Yi M, Lemon SM, (2010) Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. Journal of virology 84: 6615–6625.
31. Bukong TN, Hou W, Kodys K, Szabo G, (2013) Ethanol facilitates hepatitis C virus replication via up-regulation of GW182 and heat shock protein 90 in human hepatoma cells. Hepatology 57: 70–80.
32. Wiley RD, Gummuluru S, (2006) Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proceedings of the National Academy of Sciences of the United States of America 103: 738–743.
33. Rice CM, (2011) New insights into HCV replication: potential antiviral targets. Topics in antiviral medicine 19: 117–120.
34. Broering TJ, Garrity KA, Boatright NK, Sloan SE, Sandor F, et al. (2009) Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. Journal of virology 83: 12473–12482.
35. Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, et al. (2007) CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. Journal of virology 81: 5036–5045.
36. Bartosch B, Dubuisson J, Cosset FL, (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. The Journal of experimental medicine 197: 633–642.
37. Bukong TN, Hou W, Kodys K, Szabo G, (2012) Ethanol facilitates HCV replication via upregulation of GW182 and HSP90 in human hepatoma cells. Hepatology 10.1002/hep.26010.
38. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proceedings of the National Academy of Sciences of the United States of America 109: 941–946.
39. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proceedings of the National Academy of Sciences of the United States of America 109: 941–946.
40. Ujino S, Yamaguchi S, Shimotohno K, Takaku H, (2009) Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. J Biol Chem 284: 6841–6846.
41. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, et al. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. Journal of virology 80: 1734–1741.
42. Meertens L, Bertaux C, Dragic T, (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. Journal of virology 80: 11571–11578.
43. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, et al. (2009) Microenvironmental pH is a key factor for exosome traffic in tumor cells. The Journal of biological chemistry 284: 34211–34222.
44. Simons M, Raposo G, (2009) Exosomes–vesicular carriers for intercellular communication. Current opinion in cell biology 21: 575–581.
45. Momen-Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, et al. (2013) Current methods for the isolation of extracellular vesicles. Biological chemistry 10.1515/hsz-2013-0141.
46. Silverman JM, Reiner NE, (2011) Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cellular microbiology 13: 1–9.
47. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS, (2007) Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110: 3234–3244.
48. Ramakrishnaiah V, Thumann C, Fofana I, Habersetzer F, Pan Q, et al. (2013) Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proceedings of the National Academy of Sciences of the United States of America 110: 13109–13113.
49. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. Journal of virology 76: 13001–13014.
50. Hao J, Jin W, Li X, Wang S, Zhang X, et al. (2013) Inhibition of alpha interferon (IFN-alpha)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-alpha. J Virol 87: 137–147.
51. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W, (2009) Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nature medicine 15: 31–33.
52. Johnston M, Geoffroy MC, Sobala A, Hay R, Hutvagner G, (2010) HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells. Molecular biology of the cell 21: 1462–1469.
53. Okamoto T, Nishimura Y, Ichimura T, Suzuki K, Miyamura T, et al. (2006) Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. The EMBO journal 25: 5015–5025.
54. Ujino S, Yamaguchi S, Shimotohno K, Takaku H, (2009) Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. J Biol Chem 284: 6841–6846.
55. Thery C, Zitvogel L, Amigorena S, (2002) Exosomes: composition, biogenesis and function. Nature reviews Immunology 2: 569–579.
56. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ, (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. Journal of cell science 113 Pt 19: 3365–3374.
57. Sobota JA, Back N, Eipper BA, Mains RE, (2009) Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway proteins. Journal of cell science 122: 3542–3553.
58. Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, et al. (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiology of disease 42: 360–367.
59. Vingtdeux V, Hamdane M, Loyens A, Gele P, Drobeck H, et al. (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. The Journal of biological chemistry 282: 18197–18205.
60. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, et al. (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. Journal of virology 80: 6964–6972.
61. Lim JH, Park JW, Kim MS, Park SK, Johnson RS, et al. (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Molecular pharmacology 70: 1856–1865.
62. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623–626.
63. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, et al. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946–1957.
64. Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, et al. (1996) Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. The Journal of general virology 77 (Pt 5) 1043–1054.
65. Bukong TN, Kodys K, Szabo G, (2013) Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. Hepatology 58: 1569–1579.